Zero ad trackers.We never sell your data.Healthcare professional?Clinician Resources
Home/Rare Diseases/Hereditary Spastic Paraplegia Type 4

Neurological & Neuromuscular

Hereditary Spastic Paraplegia Type 4 (SPG4) Clinical Trials

Also called SPG4, spastic paraparesis, familial spastic paraplegia

Hereditary spastic paraplegia type 4 (SPG4) is an autosomal dominant neurodegenerative disorder caused by mutations in the SPAST gene encoding spastin, a microtubule-severing protein essential for proper intracellular transport and axonal dynamics. Spastin dysfunction impairs axonal transport capacity and microtubule dynamics, leading to progressive selective degeneration of the longest corticospinal tract axons that descend from motor cortex to spinal cord.

In plain words, hereditary spastic paraplegia type 4 is a rare inherited condition where very long nerves in the spinal cord slowly break down. The legs become stiff and weak over time, which makes walking harder.

Get an email when new Hereditary Spastic Paraplegia Type 4 trials open or the FDA decides. Get alerts

Hereditary Spastic Paraplegia Type 4

Where treatments stand, from ClinicalTrials.gov and FDA labels

Also 2 studies with no phase, like observational studies.

FDA review0

No decision pending. FDA calendar

FDA-approved medicines0

No medicine's current FDA label names Hereditary Spastic Paraplegia Type 4 yet.

Hereditary Spastic Paraplegia Type 4 has no FDA-approved medicines, 2 open or active clinical trials (2 recruiting), and no pending FDA decision.

Labels checked October 21, 2026.Download the data

Latest for Hereditary Spastic Paraplegia Type 4

See all trialsThe week in rare disease

Each date is the day a change was posted. Open an item to see where things stand now.

More about Hereditary Spastic Paraplegia Type 4

This length-dependent axonopathy particularly affects the longest neurons because they have the greatest energy and transport demands. Patients experience slowly progressive lower limb weakness and spasticity (increased muscle tone and reflexes), with highly variable age of onset ranging from childhood to late adulthood. Early-onset forms (childhood-onset) tend to progress more rapidly and lead to significant disability sooner, while late-onset forms may be relatively benign with minimal functional impact during normal lifespan.

Keep reading about Hereditary Spastic Paraplegia Type 4

As disease progresses, patients develop increasing difficulty ambulating with progressive spasticity and weakness, with some becoming wheelchair-dependent by middle age while others maintain independent ambulation throughout life. Cognitive decline occurs in some family lineages. MRI may show progressive spinal cord atrophy reflecting neuronal loss. Life expectancy is typically normal or only slightly reduced.

What are the symptoms of Hereditary Spastic Paraplegia Type 4?

These are common symptoms of Hereditary Spastic Paraplegia Type 4, and how strong they are varies from person to person.

  • Progressive lower limb weakness and stiffness
  • Spasticity affecting legs and feet
  • Hyperreflexia and Babinski sign
  • Difficulty walking and balance problems
  • Urinary urgency and incontinence
  • Cognitive decline in some cases

Who gets Hereditary Spastic Paraplegia Type 4?

Hereditary spastic paraplegia type 4 has highly variable age of onset from childhood to late adulthood, even within families. SPG4 mutations account for approximately 40% of hereditary spastic paraplegia cases overall.

The condition affects males and females equally. Since it follows autosomal dominant inheritance with incomplete penetrance, approximately 50% of offspring of affected parents inherit mutations, though some carriers may not manifest clinical disease. Penetrance appears to increase with age.

Next steps: find trials you might fitsee what is being testedget help payingget alerts

Side effects people have reported to the FDA

Side effects people have reported to the FDA

Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.

Loading side effect data...

Diagnosis and genetic testing

Genetic testing for Hereditary Spastic Paraplegia Type 4

Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.

Finding labs...

Trusted Hereditary Spastic Paraplegia Type 4 resources

Reputable organizations and medical references for learning more about Hereditary Spastic Paraplegia Type 4, including disease registries, foundation resources, and clinical guidelines.

Active clinical trials for Hereditary Spastic Paraplegia Type 4

Use this Hereditary Spastic Paraplegia Type 4 clinical trial finder to see the 2 studies recruiting patients in the United States and worldwide, with eligibility criteria in plain English. Of these, 1 tests a treatment and 1 is an observational study or registry; each card says which. Every trial comes from ClinicalTrials.gov.

Jump to the trial list, the site map or the pipeline timeline.

Note: Trial recruitment statuses on ClinicalTrials.gov may not immediately reflect recent FDA decisions, sponsor announcements, or enrollment changes. Always confirm a trial's current status directly with the study coordinator before making plans.

2 active trials worldwide
Filter:
Sort:
RecruitingObservational study, no treatment givenNo updates in a whileNCT06553976

Spastic Paraplegia - Centers of Excellence Research Network

Sponsor: Boston Children's Hospital

The Spastic Paraplegia - Centers of Excellence Research Network (SP-CERN) is a collaborative research consortium dedicated to advancing the understanding, diagnosis, and treatment of hereditary spastic paraplegia (HSP) and primary lateral sclerosis (PLS). Aims of the consortium a...

Ages not specified
Started Jun 2024Updated 8 months agoEst. Jun 2026
RecruitingTreatment trialHasn't posted an update in over a yearNCT03206190

The preSPG4 Study - Studying the Prodromal and Early Phase of SPG4

Intervention: SPRS Score and clinical signs, Cognition Testing using CANTAB, Lumbar Puncture and blood draw, MRI, Electrophysiology, Testing functional performance, Non motor symptoms

Sponsor: University Hospital Tuebingen

Study goals

1. Prospective longitudinal data on progression in the natural course of SPG4 in presymptomatic mutation carriers prior to clinical disease onset and in early stages of disease

2. Biomarkers providing objective measures of disease activity

Ages 18 Years to 70 Years1 location
Started Jul 2018Updated 4 years agoEst. Dec 2029 (~3y 1m)
Find Hereditary Spastic Paraplegia Type 4 trials near you, ranked by distance →
Active trial locations9 cities in the US
A study site. Select it to see its trials and get directions. Several sites close together. Select the number to zoom in.
+1 more

Trial Pipeline

Jan 2021 to Nov 2031
2021
2023
2025
2027
2029
2031
now
Observational
Observational
RecruitingNot yet recruitingDelayed startTodayHover a bar for trial details

Read more about Hereditary Spastic Paraplegia Type 4 trials

Need help understanding these trials?
Answers with sources, in plain English
Start withor ask
Run a Hereditary Spastic Paraplegia Type 4 foundation or patient group?
You can put this live trial list on your own website. It updates itself, and it's free.
Get the embed code →

Data from ClinicalTrials.gov, U.S. National Library of Medicine.
Always talk to your doctor before considering a clinical trial.

Hereditary Spastic Paraplegia Type 4 patient communities

Facebook groups, Reddit communities and YouTube channels where Hereditary Spastic Paraplegia Type 4 patients, caregivers and advocacy groups talk.

Questions people ask about Hereditary Spastic Paraplegia Type 4